According to tumor cell studies, AEG-1 positively activates NF-κB to downregulate EAAT-2 expression [11, 12], phosphorylates serine/threonine kinase (Akt), and contributes to infiltration and metastasis of tumor cells [13, 14, 15]. The gene discussed is MARK2; the disease is neoplasm.